Review decisions
Showing 240 results of 359 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1697728420996
Product Type: Drug
Control Number: 265427
DIN(s): 02475200, 02475219
Manufacturer: AstraZeneca Canada Inc
Submission Type: Supplement to a New Drug Submission - Notice of Compliance with Conditions
Date Filed / Submission Date: 2022-06-22
Decision / Authorization Date: 2023-07-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1690554055228
Product Type: Drug
Control Number: 266471
DIN(s): 02539845, 02539853, 02539861
Manufacturer: Eli Lilly Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-07-27
Decision / Authorization Date: 2023-07-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1691593234367
Product Type: Drug
Control Number: 266545
DIN(s): 02539977, 02539985, 02540002, 02540010, 02540029, 02540037, 02540045
Manufacturer: Baxter Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-07-29
Decision / Authorization Date: 2023-07-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692295194036
Product Type: Drug
Control Number: 270922
DIN(s): 02527049
Manufacturer: Pfizer Canada ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-12-22
Decision / Authorization Date: 2023-07-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689349413724
Product Type: Drug
Control Number: 266244
DIN(s): 02522551, 02522578, 02522586, 02522594, 02522608, 02528509, 02528517, 02528525, 02528533, 02528541
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-07-20
Decision / Authorization Date: 2023-06-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1689946984717
Product Type: Drug
Control Number: 266537
DIN(s): 02470365, 02492504, 02510049, 02524252, 02526190
Manufacturer: Sanofi-Aventis Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-08-03
Decision / Authorization Date: 2023-07-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1737486518137
Product Type: Drug
Control Number: 277139
Manufacturer: Servier Canada Inc
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2023-07-11
Issued / Original Publication Date: 2025-01-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1688740135719
Product Type: Drug
Control Number: 259302
DIN(s): 02533286
Manufacturer: VBI Vaccines Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2023-07-08
Issued / Original Publication Date: 2023-07-06
Decision / Authorization Date: 2022-12-06
Updated Date: 2024-06-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1693578801415
Product Type: Drug
Control Number: 261689
DIN(s): 02538652, 02538660, 02538725, 02538733, 02538741, 02538814
Manufacturer: Endo Ventures Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-06-09
Decision / Authorization Date: 2023-06-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1739202346124
Product Type: Drug
Control Number: 274939
DIN(s): 02550245, 02550253, 02550261
Manufacturer: Celltrion, Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-06-30
Issued / Original Publication Date: 2025-02-10
Decision / Authorization Date: 2024-07-30